Welcome to Arctom, sign up to enjoy up to 20% OFF
- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 2252262-24-9] Sabatolimab
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-P99044 |
| Brand: | MCE |
| CAS: | 2252262-24-9 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | - |
| Molecular Formula | - |
| SMILES | [Sabatolimab] |
For research use only. We do not sell to patients.
Summary
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT04823624 | Massachusetts General Hospital|Novartis |
Myelodysplastic Syndromes
|
September 2021 | Phase 2 |
| NCT04878432 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndrome (MDS)
|
March 17, 2022 | Phase 2 |
| NCT03940352 | Novartis Pharmaceuticals|Novartis |
Acute Myeloid Leukemia (AML)|High-risk Myelodysplastic Syndrome (MDS)
|
June 24, 2019 | Phase 1 |
| NCT04810611 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndromes
|
June 18, 2021 | Phase 1 |
| NCT05201066 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic
|
January 2, 2023 | Phase 2 |
| NCT04266301 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic
|
June 8, 2020 | Phase 3 |
| NCT03066648 | Novartis Pharmaceuticals|Novartis |
Leukemia|Leukemia, Myeloid|Leukemia, Myeloid, Acute|Myelodysplastic Syndromes|Preleukemia|Bone Marrow Diseases|Hematologic Diseases|Chronic Myelomonocytic Leukemia
|
July 6, 2017 | Phase 1 |
| NCT04623216 | Novartis Pharmaceuticals|Novartis |
Acute Myeloid Leukemia
|
September 14, 2021 | Phase 1|Phase 2 |
| NCT03946670 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndromes
|
June 4, 2019 | Phase 2 |
| NCT02608268 | Novartis Pharmaceuticals|Novartis |
Advanced Malignancies
|
November 23, 2015 | Phase 1|Phase 2 |
| NCT04150029 | Novartis Pharmaceuticals|Novartis |
Acute Myeloid Leukemia
|
September 1, 2020 | Phase 2 |
| NCT05367401 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndromes|Acute Myeloid Leukemia
|
December 20, 2024 | Phase 1|Phase 2 |
| NCT04097821 | Novartis Pharmaceuticals|Novartis |
Myelofibrosis
|
September 26, 2019 | Phase 1|Phase 2 |
| NCT04812548 | Novartis Pharmaceuticals|Novartis |
Myelodysplastic Syndrome (MDS)
|
May 31, 2021 | Phase 2 |
| NCT03961971 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Novartis Pharmaceuticals |
Glioblastoma Multiforme
|
February 18, 2020 | Phase 1 |
| NCT04283526 | Novartis Pharmaceuticals|Novartis |
Primary Myelofibrosis|Myelofibrosis|PMF|Post-Essential Thrombocythemia Myelofibrosis|Post-Polycythemia Vera Myelofibrosis
|
November 30, 2020 | Phase 1 |
Appearance
Liquid
Shipping
Shipping with dry ice.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Request a Quote
Please fill in your details below to request a COA for our product. We will send the COA to the provided email address promptly.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.
Information
Customer service
My account
Powered by Arctom
Copyright © 2021 Arctom. All rights reserved.